Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 2007;38:642-645
doi: 10.1161/01.STR.0000250048.42916.ad
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jander, S.
Right arrow Articles by Saleh, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jander, S.
Right arrow Articles by Saleh, A.
Related Collections
Right arrow Animal models of human disease
Right arrow Acute Cerebral Infarction
Right arrow Computerized tomography and Magnetic Resonance Imaging

(Stroke. 2007;38:642.)
© 2007 American Heart Association, Inc.


Inflammation and Stroke: Introduction

Imaging Inflammation in Acute Brain Ischemia

Sebastian Jander, MD; Michael Schroeter, MD Andreas Saleh, MD

From the Departments of Neurology (S.J., M.S.) and Diagnostic Radiology (A.S.), Heinrich-Heine-University, Düsseldorf, Germany.

Correspondence to Sebastian Jander, Department of Neurology, Heinrich-Heine-University, Moorenstr. 5, D-40225 Düsseldorf, Germany. E-mail jander{at}uni-duesseldorf.de

Abstract

Brain inflammation holds promise as a therapeutic target in subacute stages of ischemic stroke. At the cellular level, postischemic inflammation is dominated by cells of the innate immune system with resident microglia/brain macrophages and blood-derived monocytes/macrophages being the most important cell types involved. Iron oxide nanoparticles such as ultrasmall superparamagnetic iron oxide (USPIO) are novel cell-specific contrast agents for MRI. After intravenous injection USPIO is taken up by circulating phagocytic cells. USPIO-laden macrophages cause typical signal changes in MRI of infarcted brain parenchyma, which has been demonstrated in studies of both experimental ischemia and human stroke. USPIO-enhanced MRI may therefore represent an important tool to address the role of macrophages for ischemic lesion development both in basic science and clinical studies.


Key Words: acute stroke • animal models • basic science • inflammation • magnetic resonance




This article has been cited by other articles:


Home page
CirculationHome page
U. Flogel, Z. Ding, H. Hardung, S. Jander, G. Reichmann, C. Jacoby, R. Schubert, and J. Schrader
In Vivo Monitoring of Inflammation After Cardiac and Cerebral Ischemia by Fluorine Magnetic Resonance Imaging
Circulation, July 8, 2008; 118(2): 140 - 148.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
M. M. Vellinga, R. D. Oude Engberink, A. Seewann, P. J.W. Pouwels, M. P. Wattjes, S. M.A. van der Pol, C. Pering, C. H. Polman, H. E. de Vries, J. J.G. Geurts, et al.
Pluriformity of inflammation in multiple sclerosis shown by ultra-small iron oxide particle enhancement
Brain, March 1, 2008; 131(3): 800 - 807.
[Abstract] [Full Text] [PDF]